| |
| |
|
| Insider
Information: |
Mathers Edward T |
| Relationship: |
|
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
58,192,147 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$260,101,832 |
|
|
| Total
Shares |
58,192,147 |
|
|
| Total
Value |
$260,101,832 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 52.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medimmune Inc |
MEDI |
SVP, Corporate Dev. |
2006-02-03 |
0 |
2006-02-03 |
0 |
Premium* |
|
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2023-07-17 |
24,471,264 |
Premium* |
|
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
|
Bright Health Group Inc. |
BHG |
10% Owner |
|
0 |
2022-01-03 |
23,983,073 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
Director |
2022-04-11 |
0 |
2022-04-11 |
948,948 |
Premium* |
|
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
Director |
2023-03-02 |
0 |
2023-03-02 |
5,771 |
Premium* |
|
|
Korro Bio |
KRRO |
|
|
0 |
2024-04-22 |
1,090,793 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRRO |
Korro Bio |
|
– – • |
2024-04-22 |
4 |
B |
$56.00 |
$999,992 |
I/I |
17,857 |
1,090,793 |
0.01 |
- |
|
| KRRO |
Korro Bio |
10% Owner |
– – • |
2023-11-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,072,936 |
|
- |
|
| SVRA |
Savara Inc |
10% Owner |
– – • |
2023-07-17 |
4 |
B |
$3.00 |
$999,999 |
I/I |
333,333 |
24,471,264 |
1.5 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Director |
– • – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
I/I |
5,771 |
5,771 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
Director |
– • – |
2022-04-11 |
4 |
A |
$1.90 |
$1,803,001 |
I/I |
948,948 |
948,948 |
0 |
- |
|
| BHG |
Bright Health Group Inc. |
10% Owner |
– – • |
2022-01-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
23,983,073 |
|
% |
|
| GLUE |
Monte Rosa Therapeutics, ... |
10% Owner |
– – • |
2021-06-28 |
4 |
B |
$19.00 |
$19,950,000 |
I/I |
1,050,000 |
7,692,298 |
1.5 |
- |
|
| GLUE |
Monte Rosa Therapeutics, ... |
10% Owner |
– – • |
2021-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
6,642,298 |
6,642,298 |
0 |
- |
|
| SVRA |
Savara Inc |
10% Owner |
– – • |
2021-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
24,137,931 |
|
% |
|
| MEDI |
Medimmune Inc |
officerTitle |
• – – |
2006-02-03 |
4 |
S |
$32.59 |
$1,303,420 |
D/D |
(40,000) |
0 |
|
- |
|
| MEDI |
Medimmune Inc |
officerTitle |
• – – |
2006-02-03 |
4 |
OE |
$23.45 |
$954,200 |
D/D |
40,000 |
40,000 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
